GUJARAT TERCE LABORATORIES
Smallcap | BSE
Sector
Here's the live share price of Gujarat Terce Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
1.34₹ 0.47
As on Jun 10, 2026, 09:23 AM IST
Source: Dion Global
Gujarat Terce Laboratories Price Performance
Today's LowToday's High
₹35.46₹35.46
₹35.46
52 Weeks' Low52 Weeks' High
₹29.00₹60.01
₹35.46
Open Price
₹35.46
Prev. Close
₹34.99
Volume
1
Source: Dion Global
Gujarat Terce Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Gujarat Terce Laboratories | 1.42 | -3.18 | -8.67 | -22.24 | -35.43 | 4.12 | 31.20 |
| Sun Pharmaceutical Industries | -0.53 | -4.91 | -1.50 | 0.24 | 5.09 | 21.89 | 21.49 |
| Divi's Laboratories | 3.52 | 0.65 | 6.65 | 7.40 | 1.99 | 25.40 | 9.64 |
| Torrent Pharmaceuticals | 3.52 | -1.17 | 2.18 | 18.69 | 40.48 | 35.21 | 26.17 |
| Zydus Lifesciences | 2.68 | 15.62 | 21.73 | 20.24 | 13.63 | 29.68 | 11.71 |
| Cipla | -0.16 | 5.52 | 3.89 | -7.64 | -8.60 | 12.43 | 7.51 |
| Dr. Reddy's Laboratories | -0.46 | -0.86 | -1.37 | 1.81 | -3.83 | 10.75 | 3.97 |
| Lupin | 0.33 | 0.51 | -1.94 | 9.99 | 13.21 | 40.89 | 13.10 |
| Mankind Pharma | 3.98 | -3.21 | 10.54 | 9.68 | 1.43 | 17.25 | 10.91 |
| Aurobindo Pharma | 1.18 | -2.68 | 15.97 | 24.47 | 24.51 | 29.29 | 8.58 |
| Laurus Labs | 2.82 | 12.29 | 39.30 | 39.23 | 113.18 | 60.98 | 18.43 |
| Biocon | 0.02 | 6.72 | 6.91 | 8.66 | 23.26 | 20.05 | 0.60 |
| Alkem Laboratories | 2.17 | -4.39 | -1.97 | -5.51 | 9.81 | 16.20 | 11.56 |
| Glenmark Pharmaceuticals | 0.84 | -6.25 | 4.08 | 13.66 | 37.83 | 51.31 | 28.74 |
| Abbott India | -0.48 | -5.80 | -3.66 | -6.95 | -17.75 | 6.26 | 10.24 |
| Anthem Biosciences | 2.83 | -1.15 | 17.42 | 17.72 | 6.11 | 2.00 | 1.19 |
| Ipca Laboratories | 8.39 | 6.57 | 8.47 | 12.63 | 19.39 | 30.92 | 9.88 |
| Gland Pharma | 0.71 | 19.33 | 36.40 | 33.83 | 39.02 | 33.71 | -5.89 |
| Ajanta Pharma | 2.96 | -2.05 | 2.33 | 14.61 | 15.61 | 27.19 | 18.58 |
| GlaxoSmithKline Pharmaceuticals | 0.29 | -9.91 | -12.97 | -14.28 | -35.38 | 17.02 | 8.16 |
Source: Dion Global
Over the last one year, Gujarat Terce Laboratories has declined 35.43% compared to peers like Sun Pharmaceutical Industries (5.09%), Divi's Laboratories (1.99%), Torrent Pharmaceuticals (40.48%). From a 5 year perspective, Gujarat Terce Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (21.49%) and Divi's Laboratories (9.64%).
Gujarat Terce Laboratories Financials
Source: Dion Global
Gujarat Terce Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 34.73 | 34.82 |
| 10 | 34.81 | 34.85 |
| 20 | 34.97 | 35.11 |
| 50 | 35.34 | 36.12 |
| 100 | 38.67 | 38.27 |
| 200 | 41.72 | 42.37 |
Source: Dion Global
Gujarat Terce Laboratories Share Holding Pattern
In the latest quarter, Gujarat Terce Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved down to 59.97% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Gujarat Terce Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Jun 03, 2026, 10:11 PM IST IST | Guj. Terce Lab. - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Jun 01, 2026, 11:58 PM IST IST | Guj. Terce Lab. - Amendment To The Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Inform |
| May 30, 2026, 10:05 PM IST IST | Guj. Terce Lab. - Fixation Of Date Of 41St Annual General Meeting ("AGM") Of The Company For The Financial Year Ended 31 Marc |
| May 30, 2026, 04:17 AM IST IST | Guj. Terce Lab. - Fixation Of Date Of 41St Annual General Meeting ("AGM") Of The Company For The Financial Year Ended 31 Marc |
| May 30, 2026, 04:09 AM IST IST | Guj. Terce Lab. - Board Meeting Outcome for Outcome Of Board Meeting Held On 29 May 2026 |
Source: Dion Global
About Gujarat Terce Laboratories
Gujarat Terce Laboratories Ltd. is a Public Limited Listed company incorporated on 28/03/1985 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24100GJ1985PLC007753 and registration number is 007753. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 47.47 Cr. and Equity Capital is Rs. 7.79 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- Address122/2, Ravi Estate, Gandhinagar District Gujarat 382729
- Contact
Source: Dion Global
Management
- Mr. Natwarbhai P PrajapatiChairman
- Mr. Amrutbhai P PrajapatiWhole Time Director
- Mr. Aalap PrajapatManaging Director & CEO
- Mrs. Chhayaben A ShahIndependent Director
- Mr. Viplav S KhamarIndependent Director
- Mr. Surendra Kumar SharmaIndependent Director
- Mr. Navinchandra PatelIndependent Director
FAQs on Gujarat Terce Laboratories Share Price
What is the share price of Gujarat Terce Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Gujarat Terce Laboratories is ₹35.46 as on Jun 10, 2026.
What kind of stock is Gujarat Terce Laboratories?
The Gujarat Terce Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Gujarat Terce Laboratories?
The market cap of Gujarat Terce Laboratories is ₹25.96 Cr as on Jun 10, 2026.
What are today's High and Low prices of Gujarat Terce Laboratories?
Today’s highest and lowest price of Gujarat Terce Laboratories are ₹35.46 and ₹35.46.
What are the 52 Week High and 52 Week Low of Gujarat Terce Laboratories?
The 52-week high/low is the highest and lowest price at which Gujarat Terce Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Gujarat Terce Laboratories is ₹60.01 and 52-week low of Gujarat Terce Laboratories is ₹29.00 as on Jun 10, 2026.
How has the Gujarat Terce Laboratories performed historically in terms of returns?
The Gujarat Terce Laboratories has shown returns of 1.34% over the past day, -1.88% for the past month, -7.97% over 3 months, -36.3% over 1 year, 6.39% across 3 years, and 31.52% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Gujarat Terce Laboratories?
P/E ratio of and PB ratio of Gujarat Terce Laboratories are 0.00 and 3.31 on Jun 10, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global
✕